Texas Retina Clinical Research Coordinator Rachel McCullough Participates in Panel Discussion for LUGANO and LUCIA Clinical Trials
At a recent meeting in San Antonio, Texas Retina Clinical Research Coordinator Rachel McCullough participated in a panel discussion with study coordinators for EyePoint Pharmaceuticals’ pivotal Phase III LUGANO and LUCIA clinical
read more
Dr. Coors Treats First Patient in DAYBREAK Clinical Trial of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer for Wet AMD
Texas Retina’s Lori E. Coors, MD, recently enrolled and treated the first patient in the Phase III DAYBREAK trial evaluating an intravitreal tarcocimab tedromer and tabirafusp tedromer compared with intravitreal aflibercept in
read more
Three New Clinical Trials Available at Texas Retina
Medical researchers continue to make significant advances in the diagnosis and treatment of retinal conditions, and our physicians remain committed to participating in clinical trials that will improve care for our patients.
read more
Dr. Coors and Dr. Christopher Fuller Served as Invited Faculty for Retina LIVE! Surgical Case Series Event
Texas Retina Associates’ Lori E. Coors, MD, and Christopher G. Fuller, MD, joined speakers from Bascom Palmer Eye Institute, Stanford University’s Byers Eye Institute, and Duke University Eye Center as part of
read more
Getting to Know Lori E. Coors, MD
With 13 years of experience, board-certified retina specialist Lori E. Coors, MD, has been a part of Texas Retina Associates since 2005 and sees patients in our Dallas North, Plano and Sherman offices.
read more